» Articles » PMID: 23684532

Revisiting the Clinical and Histopathological Aspects of Patients with Chromoblastomycosis from the Brazilian Amazon Region

Overview
Journal Arch Med Res
Specialty General Medicine
Date 2013 May 21
PMID 23684532
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Chromoblastomycosis is a chronic fungal infection caused by species of the family Dematiaceae. Fonsecaea pedrosoi is the most common etiological agent. The objective of this study was to describe the epidemiological and mycological profile of patients with chromoblastomycosis from the Amazon region of Brazil and to correlate the clinical forms with the histopathological findings and severity criteria.

Methods: Sixty-five patients were submitted to mycological (direct, culture, and microculture) and histopathological (hematoxylin-eosin staining) examination. Severity of the disease was classified according to the criteria proposed by Carrión in 1950.

Results: Most patients were males (93.8%) and laborers (89.2%). There was a predominance of verrucous lesions (55.4%), which were mainly found on the lower limbs (81.5%). Two major types of tissue reaction were observed: a granulomatous reaction characterized by the formation of suppurative granulomas rich in fungal cells, which were almost always seen in verrucous lesions, and a reaction characterized by the formation of tuberculoid granulomas with few parasites, which were mainly found in well-delimited erythematous plaque-like and cicatricial lesions (p = 0.0001). A peculiar type of organized mycotic granuloma was observed in 20 subjects. Suppurative granulomas were more frequently detected in severe lesions (p = 0.0189) and in lesions with a duration of >10 years (p = 0.0408).

Conclusions: These results suggest that verrucous lesions present a less competent inflammatory tissue response than patients who develop a well-formed tuberculoid reaction. The latter is associated with a more effective immune response as observed in the limited clinical forms of chromoblastomycosis.

Citing Articles

New Immunological Markers in Chromoblastomycosis-The Importance of PD-1 and PD-L1 Molecules in Human Infection.

Cavallone I, Belda Jr W, de Carvalho C, Laurenti M, Passero L J Fungi (Basel). 2023; 9(12).

PMID: 38132773 PMC: 10744586. DOI: 10.3390/jof9121172.


Chromoblastomycosis: A case series from Eastern China.

Liu S, Zhi H, Shen H, Lv W, Sang B, Li Q PLoS Negl Trop Dis. 2022; 16(9):e0010800.

PMID: 36155495 PMC: 9536625. DOI: 10.1371/journal.pntd.0010800.


Accuracy of direct examination and culture as compared to the anatomopathological examination for the diagnosis of chromoblastomycosis: a systematic review.

Borges J, Ximenes B, Miranda F, Peres G, Hayasaki I, Ferro L An Bras Dermatol. 2022; 97(4):424-434.

PMID: 35643736 PMC: 9263652. DOI: 10.1016/j.abd.2021.09.007.


The global burden of chromoblastomycosis.

Santos D, de Azevedo C, Vicente V, Queiroz-Telles F, Rodrigues A, de Hoog G PLoS Negl Trop Dis. 2021; 15(8):e0009611.

PMID: 34383752 PMC: 8360387. DOI: 10.1371/journal.pntd.0009611.


Early immune response against Fonsecaea pedrosoi requires Dectin-2-mediated Th17 activity, whereas Th1 response, aided by Treg cells, is crucial for fungal clearance in later stage of experimental chromoblastomycosis.

Siqueira I, Wuthrich M, Li M, Wang H, Las-Casas L, de Castro R PLoS Negl Trop Dis. 2020; 14(6):e0008386.

PMID: 32542003 PMC: 7316354. DOI: 10.1371/journal.pntd.0008386.